Detection and characterization of drug-resistant conferring genes in Mycobacterium tuberculosis complex strains: A prospective study in two distant regions of Ghana

Tuberculosis

Volumn 99, Issue , 2016, Pages 147-154

  Otchere, I D ^a,b   Asante Poku, A ^a   Osei Wusu, S ^a   Baddoo, A ^c   Sarpong, E ^a   Ganiyu, A H ^a   Aboagye, S Y ^a   Forson, A ^c   Bonsu, F ^d   Yahayah, A I ^e   Koram, K ^a   Gagneux, S ^f,g   Yeboah Manu, D ^a  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c KORLE BU TEACHING HOSPITAL   (Ghana)

^d MINISTRY OF HEALTH   (Ghana)

^e Tamale Teaching Hospital   (Ghana)

^f SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^g UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Compensatory; Drug resistant; Mutations; Spoligotype; Virulence

Indexed keywords

ISONIAZID; KATG PROTEIN; RIFAMPICIN; BACTERIAL PROTEIN; TUBERCULOSTATIC AGENT;

ADULT; AHPCPRO GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAMEROON; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; DRUG SENSITIVITY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; GHANA; HUMAN; INHA GENE; INHAPRO GENE; MALE; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RPOB GENE; RPOC GENE; SPOLIGOTYPE; CLINICAL TRIAL; DNA MUTATIONAL ANALYSIS; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIDRUG RESISTANCE; MUTATION; PATHOGENICITY; PHENOTYPE; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; VIRULENCE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; GHANA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PROSPECTIVE STUDIES; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; VIRULENCE;

EID: 84976353343     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2016.05.014     Document Type: Article

References (39)

1. WHO (World Health Organization) Global tuberculosis report 2014 (WHO/HTM/TB/2014.08)
2. B.C. de Jong, M. Antonio, and S. Gagneux Mycobacterium africanum-review of an important cause of human tuberculosis in West Africa PLoS Negl Trop Dis 4 2010 e744
3. E.W. Orenstein, S. Basu, N.S. Shah, J.R. Andrews, G.H. Friedland, A.P. Moll, N.R. Gandhi, and A.P. Galvani Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis Lancet Infect Dis 9 2009 153 161
4. J.C. Johnston, N.C. Shahidi, M. Sadatsafavi, and J.M. Fitzgerald Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis PLoS One 4 2009 e6914
5. H. Marrakchi, G. Lanéelle, and A. Quémard InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system FAS-II Microbiol 146 2000 289 296
6. E.A. Campbell, N. Korzheva, A. Mustaev, K. Murakami, S. Nair, A. Goldfarb, and S.A. Darst Structural mechanism for rifampicin inhibition of bacterial rna polymerase Cell 104 2001 901 912
7. D. Hillemann, S. Rüsch-Gerdes, and E. Richter Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens J Clin Microbiol 45 2007 2635 2640
8. E.R.D. Costa, M.O. Ribeiro, M.S.N. Silva, L.S. Arnold, D.C. Rostirolla, P.I. Cafrune, R.C. Espinoza, M. Palaci, M.A. Telles, V. Ritacco, P.N. Suffys, M.L. Lopes, C.L. Campelo, S.S. Miranda, K. Kremer, P.E.A. da Silva, S.L. de Fonseca, J.L. Ho, A.L. Kritski, and M.L.R. Rossetti Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America BMC Microbiol 9 2009 39
9. D.R. Sherman, K. Mdluli, M.J. Hickey, T.M. Arain, S.L. Morris, and C.E. Barry Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis Science 272 1996 1641 1643
10. A. Koch, V. Mizrahi, and D.F. Warner The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin? Emerg Microbes Infect 3 2014 e17
11. I. Comas, S. Borrell, A. Roetzer, G. Rose, B. Malla, M. Kato-Maeda, J. Galagan, S. Niemann, and S. Gagneux Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes Nat Genet 44 2011 106 110
12. G. Brandis, and D. Hughes Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates J Antimicrob Chemother 68 2013 2493 2497
13. S. Gagneux, C.D. Long, P.M. Small, T. Van, G.K. Schoolnik, and B.J.M. Bohannan The competitive cost of antibiotic resistance in Mycobacterium tuberculosis Science 312 2006 1944 1946
14. S. Shanmugam, N. Selvakumar, and S. Narayanan Drug resistance among different genotypes of Mycobacterium tuberculosis isolated from patients from Tiruvallur, South India Infect Genet Evol 11 2011 980 986
15. A.S. Albanna, M.B. Reed, K.V. Kotar, F. Ashley, A.M. Fiona, A.B. Macel, and M. Dick Reduced transmissibility of East african indian strains of mycobacterium tuberculosis PLoS One 6 2011 e25075
16. D. Yeboah-manu, T. Bodmer, S. Owusu, D. Ofori-adjei, G. Pluschke, and E. Mensah-quainoo Evaluation of decontamination methods and growth media for primary isolation of Mycobacterium ulcerans from surgical specimens J Clin Microbiol 42 2004 5875 5877
17. R.M. Warren, N.C. Gey van Pittius, M. Barnard, A. Hesseling, E. Engelke, M. de Kock, M.C. Gutierrez, G.K. Chege, T.C. Victor, E.G. Hoal, and P.D. van Helden Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference Int J Tuberc Lung Dis 10 2006 818 822
18. J. Kamerbeek, L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J.D.A. van Embden Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology J Clin Microbiol 35 1997 907 914
19. J. Palomino, A. Martin, M. Camacho, H. Guerra, and J. Swings Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis Antimicrob Agents Chemother 46 2002 2720 2722
20. S.G. Franzblau, R.S. Witzig, J.C. Mclaughlin, P. Torres, G. Madico, A. Hernandez, M.T. Degnan, M.B. Cook, V.K. Quenzer, R.M. Ferguson, and R.H. Gilman Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay J Clin Microbiol 36 1998 362 366
21. D.V.A.N. Soolingen, P.W. Hermans, P.E. Haas, D.R. Soll, and J.B. van Embden Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis J Clin Microbiol 29 1991 2578 2586
22. M. Käser, M.-T. Ruf, J. Hauser, L. Marsollier, and G. Pluschke Optimized method for preparation of DNA from pathogenic and environmental mycobacteria Appl Environ Microbiol 75 2009 414 418
23. A. Asante-Poku, I.D. Otchere, E. Danso, D.D. Mensah, F. Bonsu, S. Gagneux, and D. Yeboah-Manu Evaluation of GenoType MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana Int J Tuberc Lung Dis 19 2015 954 959
24. J.M. Lew, A. Kapopoulou, L.M. Jones, and S.T. Cole TubercuList-10 years after Tuberc (Edinb) 91 1 2011 1 7
25. R. Staden, K.F. Beal, and J.K. Bonfield The Staden package, 1998 Methods Mol Biol 132 2000 115 130
26. M. Tomz, J. Wittenberg, and G. King Clarify: software for interpreting and presenting statistical results. Version 2.1 2001 Harvard Cambridge, MA
27. S. Homolka, C.G. Meyer, D. Hillemann, E. Owusu-Dabo, O. Adjei, R.D. Horstmann, E.N. Browne, A. Chinbuah, I. Osei, J. Gyapong, T. Kubica, S. Ruesch-Gerdes, and S. Niemann Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana Int J Med Microbiol 300 2010 489 495
28. D. Yeboah-manu, A. Asante-poku, T. Bodmer, D. Stucki, K. Koram, F. Bonsu, G. Pluschke, and S. Gagneux Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana PLoS One 6 2011 e21906
29. L. Wang Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang Province China Med Sci Monit 21 2015 1313 1318
30. M. Kato-Maeda, E.Y. Kim, L. Flores, L.G. Jarlsberg, D. Osmond, and P.C. Hopewell Differences among sublineages of the East-Asian lineage of Mycobacterium tuberculosis in genotypic clustering Int J Tuberc Lung Dis 14 2010 538 544
31. L. Yuan, Y. Huang, L.G. Mi, Y.X. Li, P.Z. Liu, J. Zhang, H.Y. Liang, F. Li, H. Li, S.Q. Zhang, and W.J. Li There is no correlation between sublineages and drug resistance of Mycobacterium tuberculosis Beijing/W lineage clinical isolates in Xinjiang, China Epidemiol Infect 143 2015 141 149
32. S.C.M. Ribeiro, L.L. Gomes, E.P. Amaral, M.R.M. Andrade, F.M. Almeida, A.L. Rezende, V.R. Lanes, E.C.Q. Carvalho, P.N. Suffys, I. Mokrousov, and E.B. Lasunskaia Mycobacterium tuberculosis strains of the modern sublineage of the Beijing family are more likely to display increased virulence than strains of the ancient sublineage J Clin Microbiol 52 2015 2615 2624
33. S. Niemann, R. Diel, G. Khechinashvili, M. Gegia, N. Mdivani, and Y.-W. Tang Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia J Clin Microbiol 48 2010 3544 3550
34. M. Merker, C. Blin, S. Mona, N. Duforet-Frebourg, S. Lecher, E. Willery, M.G. Blum, S. Rüsch-Gerdes, I. Mokrousov, E. Aleksic, C. Allix-Béguec, A. Antierens, E. Augustynowicz-Kopeć, M. Ballif, F. Barletta, H.P. Beck, C.E. Barry, M. Bonnet, E. Borroni, I. Campos-Herrero, D. Cirillo, H. Cox, S. Crowe, V. Crudu, R. Diel, F. Drobniewski, M. Fauville-Dufaux, S. Gagneux, S. Ghebremichael, M. Hanekom, S. Hoffner, W.W. Jiao, S. Kalon, T.A. Kohl, I. Kontsevaya, T. Lillebæk, S. Maeda, V. Nikolayevskyy, M. Rasmussen, N. Rastogi, S. Samper, E. Sanchez-Padilla, B. Savic, I.C. Shamputa, A. Shen, L.H. Sng, P. Stakenas, K. Toit, F. Varaine, D. Vukovic, C. Wahl, R. Warren, P. Supply, S. Niemann, and T. Wirth Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage Nat Genet 47 2015 242 249
35. D. Couvin, and N. Rastogi Tuberculosis - a global emergency: tools and methods to monitor, understand, and control the epidemic with specific example of the Beijing lineage Tuberc (Edinb) 95 Suppl. 1 2015 S177 S189
36. J.W. Saelens, D. Lau-Bonilla, A. Moller, N. Medina, B. Guzman, M. Calderon, R. Herrera, D.M. Sisk, A.M. Xet-Mull, J.E. Stout, E. Arathoon, B. Somayoa, and D.M. Tobin Whole genome sequencing identifies circulating Beijing-lineage Mycobacterium tuberculosis strains in Guatemala and an associated urban outbreak Tuberculosis 95 2015 810 816
37. V. Eldholm, J. Monteserin, A. Rieux, B. Lopez, B. Sobkowiak, V. Ritacco, and F. Balloux Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain Nat Commun 11 6 2015 7119 10.1038/ncomms8119
38. Björkman J. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 200; 287: 1479-1482.
39. P.E.A. Da Silva, and J.C. Palomino Molecular mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs J Antimicrob Chemother 66 7 2011 1417 1430